Evidence map›Paper›PMID 7783163›Full record

ArticleJournal of medical genetics1995

A rapid, non-radioactive screening test for fragile X mutations at the FRAXA and FRAXE loci.

Q Wang, E Green, M Bobrow, C G Mathew

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical genetics, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Age-dependent cognitive changes in carriers of the fragile X syndrome.Cortex; a journal devoted to the study of the nervous system and behavior · 2008
    Article
  6. Article
  7. Mental retardation.Indian journal of pediatrics · 2003
    Article
  8. The FRAXE Syndrome: is it time for routine screening?American journal of human genetics · 1996
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Q WangDivision of Medical and Molecular Genetics, United Medical School, Guy's Hospital, London, UK.
E Green
M Bobrow
C G Mathew
Guy's Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Screening of referrals for the mutations associated with the fragile X syndrome constitutes a significant workload in many genetics laboratories. Since the great majority of these referrals will be negative, there is a need for a rapid and inexpensive screening test. We have developed an assay which allows simultaneous amplification of the triplet repeat sequences at the FRAXA and FRAXE loci by polymerase chain reaction, and detection of the products on non-denaturing gels stained with ethidium bromide. Alleles of normal size are detected, leaving a small minority of samples to be tested by Southern blotting. A PCR based assay for detection of methylation at the CpG island upstream of the FMR-1 gene has also been devised.

Indexed as

Chromosome FragilityRNA-Binding ProteinsAllelesBase SequenceEthidiumFemaleFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeGenetic TestingHeterozygoteHumansMaleMolecular Sequence DataMutationNerve Tissue ProteinsPolymerase Chain ReactionEthidiumFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1Nerve Tissue ProteinsRNA-Binding Proteins

Identifiers

PMID7783163
PMCPMC1050311
OpenAlexW2140450160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.